Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Lung Cancer
2		Additional conditions recognized in this trial
			Carcinoma, Non-Small-Cell Lung
			Lung Neoplasms
3		More general conditions related to this trial
			Carcinoma
			Lung Diseases
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Glandular and Epithelial
			Respiratory Tract Diseases
			Respiratory Tract Neoplasms
			Thoracic Neoplasms
4		Interventions listed in this trial
			carboplatin
			docetaxel
			gemcitabine hydrochloride
			paclitaxel
			vinorelbine ditartrate
5		Additional drug interventions recognized in this trial
			Gemcitabine
			Vinblastine
			Vinorelbine
6		More general drug interventions related to this trial
			Anti-Infective Agents
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antimitotic Agents
			Antineoplastic Agents
			Antineoplastic Agents, Phytogenic
			Antiviral Agents
			Enzyme Inhibitors
			Immunologic Factors
			Immunosuppressive Agents
			Mitosis Modulators
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Radiation-Sensitizing Agents
			Therapeutic Uses
			Tubulin Modulators
7		Sponsors listed in this trial
			Japan Multinational Trial Organization